β1 adrenergic receptors in the bed nucleus of stria terminalis mediate differential responses to opiate withdrawal

Neuropsychopharmacology

Volumn 32, Issue 3, 2007, Pages 589-599

  Cecchi, Marco ^a   Capriles, Nancy ^a   Watson, Stanley J ^a   Akil, Huda ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

1 adrenergic receptors; Bed nucleus of stria terminalis; Conditioned place aversion; In situ hybridization; Individual differences; Morphine withdrawal

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETAXOLOL; CLONIDINE; MORPHINE; NALTREXOL; OPIATE; NALOXONE; NARCOTIC AGENT; NARCOTIC ANTAGONIST;

ADRENERGIC ACTIVITY; AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ABUSE; DRUG MEGADOSE; DRUG WITHDRAWAL; GENE EXPRESSION; LOW DRUG DOSE; MALE; MICROINJECTION; NONHUMAN; NORADRENERGIC SYSTEM; OPIATE ADDICTION; PHENOTYPE; PLACE PREFERENCE; PRIORITY JOURNAL; RAT; SPRAGUE DAWLEY RAT; STRIA TERMINALIS; ANIMAL; ANIMAL BEHAVIOR; AVOIDANCE BEHAVIOR; COMPARATIVE STUDY; DRUG EFFECT; GENETICS; METABOLISM; MORPHINE ADDICTION; SEPTUM NUCLEUS;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; BETAXOLOL; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MORPHINE; MORPHINE DEPENDENCE; NALOXONE; NARCOTIC ANTAGONISTS; NARCOTICS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, BETA-1; SEPTAL NUCLEI;

EID: 33847061294     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1301140     Document Type: Article

References (60)

1. Acquas E, Carboni E, Di Chiara G (1991). Profound depression of mesolimbic dopamine release after morphine withdrawal in dependent rats. Eur J Pharmacol 193: 133-134.
2. Ambrosio E, Goldberg SR, Elmer GI (1995). Behavior genetic investigation of the relationship between spontaneous locomotor activity and the acquisition of morphine self-administration behavior. Behav Pharmacol 6: 229-237.
3. Aston-Jones G, Delfs JM, Druhan J, Zhu Y (1999). The bed nucleus of the stria terminalis. A target site for noradrenergic actions in opiate withdrawal. Ann NY Acad Sci 877: 486-498.
4. Aston-Jones G, Harris GC (2004). Brain substrates for increased drug seeking during protracted withdrawal. Neuropharmacology 47(Suppl 1): 167-179.
5. Blasig J, Herz A, Reinhold K, Zieglgansberger S (1973). Development of physical dependence on morphine in respect to time and dosage and quantification of the precipitated withdrawal syndrome in rats. Psychopharmacologia 33: 19-38.
6. Cecchi M, Khoshbouei H, Javors M, Morilak DA (2002). Modulatory effects of norepinephrine in the lateral bed nucleus of the stria terminalis on behavioral and neuroendocrine responses to acute stress. Neuroscience 112: 13-21.
7. Cicero TJ, Nock B, Meyer ER (2002). Gender-linked differences in the expression of physical dependence in the rat. Pharmacol Biochem Behav 72: 691-697.
8. Cloninger CR (1987). A systematic method for clinical description and classification of personality variants. A proposal. Arch Gen Psychiat 44: 573-588.
9. Conover WJ (1999). Practical Nonparametric Statistics. Wiley: New York.
10. Day HE, Campeau S, Watson Jr SJ, Akil H (1997). Distribution of alpha 1a-, alpha 1b- and alpha 1d-adrenergic receptor mRNA in the rat brain and spinal cord. J Chem Neuroanat 13: 115-139.
11. Day HE, Curran EJ, Watson Jr SJ, Akil H (1999). Distinct neurochemical populations in the rat central nucleus of the amygdala and bed nucleus of the stria terminalis: evidence for their selective activation by interleukin-1beta. J Comp Neurol 413: 113-128.
12. De Vries TJ, Shippenberg TS (2002). Neural systems underlying opiate addiction. J Neurosci 22: 3321-3325.
13. Delfs JM, Zhu Y, Druhan JP, Aston-Jones G (2000). Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion. Nature 403: 430-434.
14. Deroche V, Piazza PV, Le Moal M, Simon H (1993). Individual differences in the psychomotor effects of morphine are predicted by reactivity to novelty and influenced by corticosterone secretion. Brain Res 623: 341-344.
15. Diana M, Pistis M, Muntoni A, Gessa G (1995). Profound decrease of mesolimbic dopaminergic neuronal activity in morphine withdrawn rats. J Pharmacol Exp Ther 272: 781-785.
16. Domyancic AV, Morilak DA (1997). Distribution of alpha1A adrenergic receptor mRNA in the rat brain visualized by in situ hybridization. J Comp Neurol 386: 358-378.
17. Dong HW, Petrovich GD, Watts AG, Swanson LW (2001). Basic organization of projections from the oval and fusiform nuclei of the bed nuclei of the stria terminalis in adult rat brain. J Comp Neurol 436: 430-455.
18. Dumont EC, Williams JT (2004). Noradrenaline triggers GABAA inhibition of bed nucleus of the stria terminalis neurons projecting to the ventral tegmental area. J Neurosci 24: 8198-8204.
19. Erb S, Stewart J (1999). A role for the bed nucleus of the stria terminalis, but not the amygdala, in the effects of corticotropinreleasing factor on stress-induced reinstatement of cocaine seeking. J Neurosci 19: RC35.
20. Frenois F, Cador M, Caille S, Stinus L, Le Moine C (2002). Neural correlates of the motivational and somatic components of naloxone-precipitated morphine withdrawal. Eur J Neurosci 16: 1377-1389.
21. Fuentealba JA, Forray MI, Gysling K (2000). Chronic morphine treatment and withdrawal increase extracellular levels of norepinephrine in the rat bed nucleus of the stria terminalis. J Neurochem 75: 741-748.
22. Gabilondo AM, Garcia-Sevilla JA (1995). Spontaneous withdrawal from long-term treatment with morphine accelerates the turnover of alpha 2-adrenoceptors in the rat brain: up-regulation of receptors associated with increased receptor appearance. J Neurochem 64: 2590-2597.
23. Georges F, Aston-Jones G (2002). Activation of ventral tegmental area cells by the bed nucleus of the stria terminalis: a novel excitatory amino acid input to midbrain dopamine neurons. J Neurosci 22: 5173-5187.
24. Gowing LR, Farrell M, Ali RL, White JM (2002). Alpha2-adrenergic agonists in opioid withdrawal. Addiction 97: 49-58.
25. Gracy KN, Dankiewicz LA, Koob GF (2001). Opiate withdrawalinduced fos immunoreactivity in the rat extended amygdala parallels the development of conditioned place aversion. Neuropsychopharmacology 24: 152-160.
26. Gutstein HB, Akil H (2001). Opioid analgesics. In: Hardman JG, Limbird LE, Goodman Gilman A (eds). The Pharmacological Basis of Therapeutics, 10th edn. McGraw-Hill: New York, NY. pp 569-619.
27. Hamlin AS, Buller KM, Day TA, Osborne PB (2004). Effect of naloxone-precipitated morphine withdrawal on c-fos expression in rat corticotropin-releasing hormone neurons in the paraventricular hypothalamus and extended amygdala. Neurosci Lett 362: 39-43.
28. Hopkins DA, Holstege G (1978). Amygdaloid projections to the mesencephalon, pons and medulla oblongata in the cat. Exp Brain Res 32: 529-547.
29. Hornby PJ, Piekut DT (1989). Opiocortin and catecholamine input to CRF-immunoreactive neurons in rat forebrain. Peptides 10: 1139-1146.
30. Howland JG, Taepavarapruk P, Phillips AG (2002). Glutamate receptor-dependent modulation of dopamine efflux in the nucleus accumbens by basolateral, but not central, nucleus of the amygdala in rats. J Neurosci 22: 1137-1145.
31. Isgor C, Cecchi M, Kabbaj M, Akil H, Watson SJ (2003). Estrogen receptor beta in the paraventricular nucleus of hypothalamus regulates the neuroendocrine response to stress and is regulated by corticosterone. Neuroscience 121: 837-845.
32. Kabbaj M, Isgor C, Watson SJ, Akil H (2002). Stress during adolescence alters behavioral sensitization to amphetamine. Neuroscience 113: 395-400.
33. Kabbaj M, Norton CS, Kollack-Walker S, Watson SJ, Robinson TE, Akil H (2001). Social defeat alters the acquisition of cocaine selfadministration in rats: role of individual differences in cocainetaking behavior. Psychopharmacology (Berlin) 158: 382-387.
34. Kimes AS, Bell JA, London ED (1990). Clonidine attenuates increased brain glucose metabolism during naloxone-precipitated morphine withdrawal. Neuroscience 34: 633-644.
35. Kosten TR, O'Connor PG (2003). Management of drug and alcohol withdrawal. N Engl J Med 348: 1786-1795.
36. Lee Y, Davis M (1997). Role of the hippocampus, the bed nucleus of the stria terminalis, and the amygdala in the excitatory effect of corticotropin-releasing hormone on the acoustic startle reflex. J Neurosci 17: 6434-6446.
37. Leri F, Flores J, Rodaros D, Stewart J (2002). Blockade of stressinduced but not cocaine-induced reinstatement by infusion of noradrenergic antagonists into the bed nucleus of the stria terminalis or the central nucleus of the amygdala. J Neurosci 22: 5713-5718.
38. McNally GP, Akil H (2002). Role of corticotropin-releasing hormone in the amygdala and bed nucleus of the stria terminalis in the behavioral, pain modulatory, and endocrine consequences of opiate withdrawal. Neuroscience 112: 605-617.
39. Mucha RF (1987). Is the motivational effect of opiate withdrawal reflected by common somatic indices of precipitated withdrawal? A place conditioning study in the rat. Brain Res 418: 214-220.
40. Nicholas AP, Pieribone VA, Hokfelt T (1993a). Cellular localization of messenger RNA for beta-1 and beta-2 adrenergic receptors in rat brain: an in situ hybridization study. Neuroscience 56: 1023-1039.
41. Nicholas AP, Pieribone V, Hokfelt T (1993b). Distributions of mRNAs for alpha-2 adrenergic receptor subtypes in rat brain: an in situ hybridization study. J Comp Neurol 328: 575-594.
42. O'Connor PG, Carroll KM, Shi JM, Schottenfeld RS, Kosten TR, Rounsaville BJ (1997). Three methods of opioid detoxification in a primary care setting. A randomized trial. Ann Intern Med 127: 526-530.
43. Paxinos G, Watson C (1998). The Rat Brain in Stereotaxic Coordinates, 4th edn. Academic Press: San Diego.
44. Phelix CF, Liposits Z, PaullWK (1994). Catecholamine-CRF synaptic interaction in a septal bed nucleus: afferents of neurons in the bed nucleus of the stria terminalis. Brain Res Bull 33: 109-119.
45. Piazza PV, Deminiere JM, Le Moal M, Simon H (1989). Factors that predict individual vulnerability to amphetamine self-administration. Science 245: 1511-1513.
46. Pieribone VA, Nicholas AP, Dagerlind A, Hokfelt T (1994). Distribution of alpha 1 adrenoceptors in rat brain revealed by in situ hybridization experiments utilizing subtype-specific probes. J Neurosci 14: 4252-4268.
47. Pothos E, Rada P, Mark GP, Hoebel BG (1991). Dopamine microdialysis in the nucleus accumbens during acute and chronic morphine, naloxone-precipitated withdrawal and clonidine treatment. Brain Res 566: 348-350.
48. Reti IM, Baraban JM (2003). Opiate withdrawal induces Narp in the extended amygdala. Neuropsychopharmacology 28: 1606-1613.
49. Rossetti ZL, Hmaidan Y, Gessa GL (1992). Marked inhibition of mesolimbic dopamine release: a common feature of ethanol, morphine, cocaine and amphetamine abstinence in rats. Eur J Pharmacol 221: 227-234.
50. Scheinin M, Lomasney JW, Hayden-Hixson DM, Schambra UB, Caron MG, Lefkowitz RJ et al (1994). Distribution of alpha 2-adrenergic receptor subtype gene expression in rat brain. Brain Res Mol Brain Res 21: 133-149.
51. Senay EC, Dorus W, Goldberg F, Thornton W (1977). Withdrawal from methadone maintenance. Rate of withdrawal and expectation. Arch Gen Psychiat 34: 361-367.
52. Smith CB, Moises HC, Spengler RN, Hollingsworth PJ (1989). Changes in alpha 2-adrenoceptor number and function in brains of morphine-dependent rats. Eur J Pharmacol 161: 111-119.
53. Stella L, De Novellis V, Vitelli MR, Capuano A, Mazzeo F, Berrino L et al (2003). Interactive role of adenosine and dopamine in the opiate withdrawal syndrome. Naunyn Schmiedebergs Arch Pharmacol 368: 113-118.
54. Stine SM, Southwick SM, Petrakis IL, Kosten TR, Charney DS, Krystal JH (2002). Yohimbine-induced withdrawal and anxiety symptoms in opioid-dependent patients. Biol Psychiat 51: 642-651.
55. Swanson LW, Petrovich GD (1998). What is the amygdala? Trends Neurosci 21: 323-331.
56. Veinante P, Stoeckel ME, Lasbennes F, Freund-Mercier MJ (2003). c-Fos and peptide immunoreactivities in the central extended amygdala of morphine-dependent rats after naloxone-precipitated withdrawal. Eur J Neurosci 18: 1295-1305.
57. Watanabe T, Nakagawa T, Yamamoto R, Maeda A, Minami M, Satoh M (2003). Involvement of noradrenergic system within the central nucleus of the amygdala in naloxone-precipitated morphine withdrawal-induced conditioned place aversion in rats. Psychopharmacology (Berlin) 170: 80-88.
58. Watanabe T, Yamamoto R, Maeda A, Nakagawa T, Minami M, Satoh M (2002). Effects of excitotoxic lesions of the central or basolateral nucleus of the amygdala on naloxone-precipitated withdrawal-induced conditioned place aversion in morphinedependent rats. Brain Res 958: 423-428.
59. Yasui Y, Tsumori T, Oka T, Yokota S (2004). Amygdaloid axon terminals are in contact with trigeminal premotor neurons in the parvicellular reticular formation of the rat medulla oblongata. Brain Res 1016: 129-134.
60. Zuckerman M, Neeb M (1979). Sensation seeking and psychopathology. Psychiat Res 1: 255-264.